MCAS Symptoms Explained: 5 Key Indicators To Watch For
Understand mast cell activation syndrome symptoms, diagnosis, and management for better health outcomes.
Mast cell activation syndrome (MCAS) is a condition where mast cells, a type of immune cell, release excessive chemical mediators like histamine, leading to recurrent episodes of severe symptoms affecting multiple body systems. These episodes can mimic anaphylaxis but occur without clear triggers, impacting skin, gastrointestinal, cardiovascular, respiratory, and neurological functions.
What Is Mast Cell Activation Syndrome?
Mast cells are part of the immune system, residing in tissues like skin, gut, and lungs, where they release mediators to fight allergens and infections. In MCAS, these cells become hyperactive, degranulating inappropriately and causing inflammation, allergy-like symptoms, and potential anaphylaxis. Unlike mastocytosis, which involves abnormal mast cell proliferation, MCAS features normal mast cell numbers but excessive activation.
MCAS is classified as primary (linked to clonal mast cell disorders like mastocytosis), secondary (triggered by allergies or other conditions), or idiopathic (no identifiable cause). Symptoms must involve at least two organ systems and respond to mast cell-targeted therapies for diagnosis.
MCAS Symptoms
MCAS symptoms are multisystemic and episodic, often severe and unpredictable. They result from mediators like histamine, prostaglandins, and cytokines causing vasodilation, smooth muscle contraction, and nerve stimulation.
- Skin symptoms: Flushing (reddening that may migrate), hives (urticaria), itching (pruritus), and angioedema (swelling, especially lips/tongue). Flushing differs from typical reactions by lasting longer without sweating.
- Gastrointestinal symptoms: Nausea, vomiting, diarrhea, constipation, abdominal pain/cramps, bloating, reflux, and dysphagia. These can lead to malabsorption or mimic irritable bowel syndrome (IBS).
- Cardiovascular symptoms: Tachycardia (rapid heart rate), hypotension (low blood pressure), blood pressure fluctuations, syncope (fainting), and chest pain. Postural orthostatic tachycardia syndrome (POTS) overlaps frequently.
- Respiratory symptoms: Shortness of breath, wheezing, nasal congestion/itching, rhinorrhea, throat swelling, and bronchospasm. Upper airway angioedema is rare but serious.
- Neurological/psychiatric symptoms: Fatigue, brain fog, cognitive dysfunction, headaches, anxiety, mood changes, and weakness. These may stem from mediator effects or chronic illness burden.
Other signs include eye irritation, lymph node swelling, joint pain, and temperature sensitivity. Episodes can be triggered by stress, weather changes, foods, exercise, or infections, though idiopathic cases lack patterns.
Causes and Risk Factors of MCAS
The exact cause of MCAS remains unclear, but mast cells in affected individuals are hypersensitive, releasing mediators without specific allergens. Genetic factors, environmental stressors, infections, or conditions like Ehlers-Danlos syndrome (EDS) may contribute.
Associations exist with POTS, EDS, and long COVID, suggesting shared pathways like autonomic dysfunction or chronic inflammation. Stress and hormonal changes exacerbate episodes.
How Is MCAS Diagnosed?
Diagnosing MCAS is challenging due to symptom overlap with allergies, IBS, or anxiety. It requires clinical criteria:
- Typical symptoms in ≥2 organ systems.
- Evidence of mast cell activation (elevated tryptase, histamine, prostaglandins, or chromogranin A during episodes).
- Response to mast cell stabilizers or antihistamines.
- Exclusion of other disorders (e.g., mastocytosis via bone marrow biopsy if needed).
Blood/urine tests during symptoms are key; baseline tryptase >20% above normal supports diagnosis. Allergy testing rules out IgE-mediated reactions.
| Test | Purpose | Timing |
|---|---|---|
| Serum tryptase | Mast cell degranulation marker | During/within 4 hours of episode |
| 24-hour urine N-methylhistamine or prostaglandins | Mediator metabolites | During episode |
| Chromogranin A | Supporting marker | During symptoms |
Consult allergists or immunologists experienced in mast cell disorders.
MCAS Treatment
Treatment targets symptom relief and mediator blockade, as no cure exists. A stepwise approach includes:
- H1 antihistamines (e.g., cetirizine, loratadine) for itching, flushing, hives.
- H2 antihistamines (e.g., famotidine) for GI reflux, heartburn.
- Mast cell stabilizers (e.g., cromolyn sodium) to prevent degranulation.
- Leukotriene inhibitors (e.g., montelukast) for respiratory symptoms.
- EpiPen for anaphylaxis risk.
- Low-histamine diet, stress management, avoiding triggers.
Advanced cases may use omalizumab (anti-IgE) or tyrosine kinase inhibitors. Lifestyle modifications like gentle exercise and sleep hygiene help.
Living With MCAS
MCAS management involves trigger avoidance, medication adherence, and support networks. Patients should wear medical alert bracelets, track episodes, and coordinate multidisciplinary care (allergist, gastroenterologist, cardiologist).
Prognosis varies; many achieve symptom control with treatment. Research into pathogenesis advances, promising targeted therapies.
Frequently Asked Questions (FAQs)
What are the most common MCAS symptoms?
Common symptoms include flushing, hives, diarrhea, abdominal pain, tachycardia, shortness of breath, and fatigue affecting skin, GI, and cardiovascular systems.
Is MCAS the same as mastocytosis?
No. Mastocytosis involves mast cell proliferation; MCAS is inappropriate activation without proliferation, though symptoms overlap.
Can MCAS cause anaphylaxis?
Yes, severe episodes mimic anaphylaxis with hypotension, airway swelling, and shock, requiring epinephrine.
How do you test for MCAS?
Diagnosis uses symptom history, elevated mediators (tryptase, etc.) during flares, treatment response, and ruling out mimics.
What triggers MCAS episodes?
Triggers vary: stress, temperature changes, foods, exercise, infections. Idiopathic cases lack clear patterns.
Is there a cure for MCAS?
No cure, but symptoms are manageable with antihistamines, stabilizers, and lifestyle changes.
References
- Mast Cell Activation Syndrome (MCAS): Symptoms & Treatment — Cleveland Clinic. 2023-10-12. https://my.clevelandclinic.org/health/diseases/mast-cell-activation-syndrome
- Mast cell activation syndrome: An up-to-date review of literature — PMC (National Library of Medicine). 2024-07-15. https://pmc.ncbi.nlm.nih.gov/articles/PMC11212760/
- Mast Cell Activation Syndrome (MCAS) — American Academy of Allergy, Asthma & Immunology (AAAAI). 2024-01-01. https://www.aaaai.org/conditions-treatments/related-conditions/mcas
- 7 Root Causes of Mast Cell Activation Syndrome (MCAS) — EDS Clinic. 2023-05-20. https://www.eds.clinic/articles/7-root-causes-of-mast-cell-activation-syndrome-mcas
Similar Articles
Read full bio of Sneha Tete
